Search results

By preventing sugar uptake, researchers succeeded in increasing the cancer cells’ sensitivity to chemotherapeutic treatment. The studies, led by researchers at Lund University in Sweden, were carried out on cancer cells in a lab environment. The results were recently published in the research journal Haematologica. Just like the body’s cells, cancer cells need energy like the sugar molecule, gluco

https://www.lucc.lu.se/article/starved-cancer-cells-became-more-sensitive-chemotherapy - 2025-10-27

A new way of identifying cancer biomarkers has been developed by researchers at Lund University in Sweden. The new technology allows very sensitive, quick and cost-effective identification of cancer biomarkers. The research is published in Nature Communications Biology. Today, every third person will get cancer in their lifetime, and the current trend suggests that in a few years that number will

https://www.lucc.lu.se/article/novel-biomarker-technology-cancer-diagnostics - 2025-10-27

A new and promising approach for treatment of lung cancer has been developed by researchers at Lund University. The treatment combines a novel surgical approach with smart nanoparticles to specifically target lung tumors. The new study has been published in the July issue of Advanced Therapeutics. Lung tumors are often difficult to remove using current surgical techniques due to their location in

https://www.lucc.lu.se/article/new-promising-treatment-uses-smart-nanoparticles-target-lung-cancer - 2025-10-27

A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer. PDE5 inhibitors include a few approved drugs in which sildenafil (Viagra) is the most well-known. The article is published in Nature Communications. “Available preclinical eviden

https://www.lucc.lu.se/article/potency-enhancing-drugs-linked-decreased-risks-men-colorectal-cancer - 2025-10-27

Emma Hammarlund was one of six researchers from Lund University in Sweden that was granted five-year starting grants from the European Research Council. Emma Hammarlund, geobiologist and researcher at the Division of Translational Cancer Research, will investigate how life could develop on our planet. The availability of oxygen has long been the prime focus for different hypotheses, however resear

https://www.lucc.lu.se/article/lucc-researcher-receive-erc-starting-grant - 2025-10-27

Researchers at Lund University in Sweden have developed a computational model which is effective in detecting and identifying genetic mutations in breast tumours. The study, the largest of its kind in the world, includes results from over 3 200 patients with breast cancer. The researchers used RNA sequencing, a sensitive, precise tool which has very gradually started to be applied clinically, alth

https://www.lucc.lu.se/article/new-analytical-model-detects-mutations-breast-cancer - 2025-10-27

A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine. Every year, about 800 children in the US are diagnosed with neuroblastoma, an aggressive cancer of the nervous system that most frequently arises in the adrenal glands

https://www.lucc.lu.se/article/promising-treatment-aggressive-childhood-cancer - 2025-10-27

Progress Report LBIC June 2011 (pdf 1,6 MB)

https://www.lbic.lu.se/article/lbic-progress-report - 2025-10-27

Efter flera års arbete har Kirik och hans samarbetspartners lyckats ta fram ett helt nytt instrument som ”hyperpolariserar” molekyler och därmed gör dem möjliga att spåra med magnetresonansavbildning (MRI). Det nya instrumentet är det enda i sitt slag i Norden och tekniken öppnar upp en helt ny värld av möjligheter för att i detalj studera hur nervceller fungerar. Projektet har möjliggjorts genom

https://www.lbic.lu.se/article/nytt-instrument-tillgangligt - 2025-10-27

Under hösten blev det klart att Sverige ska få en magnetkamera med fältstyrkan sju tesla. Vetenskapsrådet har beviljat medel för en anläggning för ultrahögfälts-MR. Artikel i Dagens Medicin

https://www.lbic.lu.se/article/medel-ny-7t-mr-kamera-beviljat - 2025-10-27

LBIC info 101101 (Word document 16,2 kB)

https://www.lbic.lu.se/article/lbic-info-november-2010 - 2025-10-27

Progress Report LBIC June 2010 (pdf 1,6 MB)

https://www.lbic.lu.se/article/lbic-progress-report-june-2010 - 2025-10-27

This year’s World Molecular Imaging Congress (WMIC) is transitioned to a virtual format due to the COVID-19 situation. The congress will be on the 5-8th of October and although the meeting is virtual all the scientific aspects of the program is fully intact. LBIC is represented by PhD Marie Sydoff, who will have a talk at the MILabs’ Scientific Industry Workshop with the title: “The High-resolutio

https://www.lbic.lu.se/article/dr-marie-sydoff-talk-world-molecular-imaging-congress-2021 - 2025-10-27

Bergmanlabora is arranging an “Improving on Perfection Tour” and will be holding a presentation and demonstrations of the new system in four cities in Sweden. Monday, Oct 18th they will visit Lund. Don’t miss this opportunity! Presentation Date: Monday, Oct 18 Time: 13:00 – 14:00 (CET) Place: Belfragesalen (Room: D1539a). Demonstrations Date: Tuesday, Oct 19 – Thursday, Oct 21 Start time: 08:30, 1

https://www.lbic.lu.se/article/bergmanlaboras-nikon-ax-r-confocal-improving-perfection-tour - 2025-10-27

Lund University Bioimaging Centre, Miltenyi Biotec Nordics and The Danish Life Science Cluster are pleased to invite you to a full day of exciting 3D imaging presentations and discussions. Come and find out how 3D imaging and lightsheet microscopy is moving science forward. Meet the experts: Ali Ertürk, Director Institute for Tissue Engineering and Regenerative Medicine (iTERM) Helmholtz Zentrum M

https://www.lbic.lu.se/article/meet-lightsheet-microscopy-experts - 2025-10-27

Researchers at Lund University have lately received a lot of attention for their work on a new stimulation method, using ultra-thin microelectrodes, to combat severe pain. This provides effective and personalised pain relief without the common side effects from pain relief drugs.  The study, 3D microelectrode cluster and stimulation paradigm yield powerful analgesia without noticeable adverse effe

https://www.lbic.lu.se/article/lbic-user-publish-their-work-science-advances - 2025-10-27

In spring 2022, Lund University Bioimaging Centre (LBIC) will give a graduate course in preclinical imaging. The course aims to give PhD students, post-docs, researchers and others theoretical and practical experiences of LBICs preclinical imaging modalities. It will provide a base which helps to incorporate different imaging technologies into the scientific questions to be answered within biomedi

https://www.lbic.lu.se/article/attend-our-graduate-course-preclinical-imaging - 2025-10-27

The National 7T MR facility in Lund is finally reviving the 7T User Meetings after a few years pause due to the pandemic. Main aims of the meeting are to exchange experiences and discuss needs and challenges, and to learn from each other! Reflecting this, the presentations will be of projects in various stages; some may only be conceptual ideas, others are running and yet other are finalized. Ever

https://www.lbic.lu.se/article/attend-swedish-7t-user-meeting - 2025-10-27

In spring 2023, Lund University Bioimaging Centre (LBIC) will give a graduate course in preclinical imaging. The course aims to give PhD students, post-docs, researchers and others theoretical and practical experiences of LBICs preclinical imaging modalities. It will provide a base which helps to incorporate different imaging technologies into the scientific questions to be answered within biomedi

https://www.lbic.lu.se/article/attend-our-graduate-course-preclinical-imaging-0 - 2025-10-27

John Stegmayr, har fått 700 000 kronor från Carl Tesdorfps Stiftelse för att vidareutveckla forskningen kring den svåra sjukdomen idiopatisk lungfibros. Pengarna är avsedda för en ny utrustning, ett så kallat SmartBatch+-system, för att förbättra möjligheterna till att visualisera tjockare prover med fluorescensmikroskopi. Processen, som kallas ”optical clearing”, finns redan idag men tillvägagång

https://www.lbic.lu.se/article/ny-utrustning-nya-mojligheter - 2025-10-27